Download Full Text (501 KB)
WSU Medical School
Wayne State University
Anti-tumor necrosis factor (TNF) agents are used to treat various inflammatory disorders, such as rheumatoid arthritis, irritable bowel disease, and hidradenitis suppurativa (HS). A known side effect of these agents is the development of autoimmunity with the formation of antinuclear antibodies and/or anti-dsDNA antibodies. Although patients sometimes develop these antibodies, they rarely exhibit clinical manifestations. If symptoms do develop, the diagnosis of anti-TNF induced lupus (ATIL) should be considered. We describe a case of adalimumab-induced lupus in a patient with hidradenitis suppurativa.
Turk, Dilara; Vellaichamy, Gautham; Lyons, Alexis; Parks-Miller, Angela; Nelson, Tamara; Meysami, Alireza; and Hamzavi, Iltefat, "Adalimumab-induced lupus in a patient with hidradenitis suppurativa" (2019). Case Reports. 113.